Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivent effects on exercise kinetics in COPD
NCT00354354Phase 4Completed
- Sponsor
- Queen's University
- Start
- Mar 2006
- Primary completion
- Jul 2009
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Combivent Sequence with Placebo Sequence (2 arms). Primary endpoints: Ventilatory Equivalent for Oxygen Kinetics, Carbon Dioxide Output Kinetics and 4 more. Started Mar 2006; status: completed.
02
Drugs
Combivent
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00354354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354354.